Loading...
XNAS
GCTK
Market cap4mUSD
Jun 06, Last price  
0.14USD
1D
4.80%
1Q
-60.98%
IPO
-99.82%
Name

GlucoTrack Inc

Chart & Performance

D1W1MN
P/E
0.18
P/S
—
EPS
0.79
Div Yield, %
—
Shrs. gr., 5y
94.32%
Rev. gr., 5y
8.45%
Revenues
0k
0000059,775143,167611,689589,46243,488208,76200000
Net income
23m
P
-1,202,296-2,788,446-2,364,339-2,772,307-9,796,8532,980,426-5,842,172-5,409,737-10,328,806-6,715,420-3,516,189-2,598,000-4,100,000-4,438,000-7,097,00022,597,000
CFO
-12m
L+90.45%
-1,367,837-1,916,113-2,296,989-3,217,767-3,361,645-4,565,224-5,311,830-5,895,119-4,892,277-3,899,087-3,501,000-3,769,000-3,729,000-6,558,000-12,490,000

Profile

GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.
URL
http://www.integrity-app.com/
IPO date
Apr 09, 2013
Employees
Domiciled in
IL
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
7,117
4,444
Unusual Expense (Income)
NOPBT
(7,117)
(4,444)
NOPBT Margin
Operating Taxes
3
Tax Rate
NOPAT
(7,117)
(4,447)
Net income
22,597
-418.40%
(7,097)
59.91%
(4,438)
8.24%
Dividends
Dividend yield
Proceeds from repurchase of equity
9,283
8,730
BB yield
-7.54%
-804.04%
Debt
Debt current
26
Long-term debt
92
196
195
Deferred revenue
Other long-term liabilities
17,624
Net debt
(5,499)
(4,296)
(2,132)
Cash flow
Cash from operating activities
(12,490)
(6,558)
(3,729)
CAPEX
(104)
(1,000)
Cash from investing activities
(104)
1,000
Cash from financing activities
13,743
8,730
FCF
(127)
(7,104)
(4,378)
Balance
Cash
5,617
4,492
2,312
Long term investments
15
Excess cash
5,617
4,492
2,327
Stockholders' equity
(132,457)
(109,769)
(101,869)
Invested Capital
137,140
113,162
103,294
ROIC
ROCE
EV
Common stock shares outstanding
330,171
4,152
15,475
Price
0.37
42.64%
0.26
-81.45%
1.41
-66.19%
Market cap
123,154
11,242.61%
1,086
-95.02%
21,819
-66.13%
EV
117,655
(3,210)
19,687
EBITDA
36
(7,104)
(4,421)
EV/EBITDA
3,268.19
0.45
Interest
3
Interest/NOPBT